We are live on
!
Find out more
UBS O'Connor Portfolio holdings
AUM
$3.76B
Turnover
54.76%
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
(-38%)
Cap. Flow
-$3.75B
Cap. Flow
% of AUM
-69.25%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 3 |
First Horizon
FHN
|
+$107M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$96.9M |
| 5 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$64.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
| 5 |
Rogers Corp
ROG
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.7% |
| 2 | Technology | 18.31% |
| 3 | Healthcare | 15.11% |
| 4 | Miscellaneous | 11.75% |
| 5 | Real Estate | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BRIV
476
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
| $1.63M | 0.03% |
163,565
-1,601
| -1% | -$15.8K |
2021 Q3
5 quarters
|
|
477
PUT
Invesco QQQ Trust
QQQ
$487B
| $1.63M | 0.03% |
+200,000
| New | +$55.3M |
2022 Q4
0 quarters
|
|
478
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
| $1.61M | 0.03% |
160,410
-1,570
| -1% | -$15.6K |
2021 Q3
5 quarters
|
|
|
SPNE
479
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.6M | 0.03% |
191,210
+30,191
| +19% | +$203K |
2022 Q1
3 quarters
|
|
480
Antero Resources
AR
$11.2B
| $1.6M | 0.03% |
51,514
+9,646
| +23% | +$333K |
2022 Q2
2 quarters
|
|
|
CORS
481
DELISTED
Corsair Partnering Corporation
CORS
| $1.59M | 0.03% |
158,743
-1,554
| -1% | -$15.3K |
2021 Q3
5 quarters
|
|
482
Schrodinger
SDGR
$1.91B
| $1.59M | 0.03% |
85,081
+5,534
| +7% | +$115K |
2022 Q1
3 quarters
|
|
483
Welltower
WELL
$169B
| $1.57M | 0.03% |
23,887
-214,330
| -90% | -$13.8M |
2022 Q3
1 quarter
|
|
484
Cheer Holding
CHR
$3.64M
| $1.55M | 0.03% |
710
| – | – |
2022 Q3
1 quarter
|
|
485
GE HealthCare
GEHC
$31.8B
| $1.54M | 0.03% |
+26,400
| New | +$1.52M |
2022 Q4
0 quarters
|
|
|
REVE
486
DELISTED
Alpine Acquisition Corp
REVE
| $1.48M | 0.03% |
141,786
-1,388
| -1% | -$14.3K |
2021 Q4
4 quarters
|
|
|
GSQB
487
DELISTED
G Squared Ascend II Inc.
GSQB
| $1.44M | 0.03% |
141,786
-1,388
| -1% | -$13.9K |
2021 Q3
5 quarters
|
|
|
NVSA
488
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
| $1.43M | 0.03% |
141,548
-1,391
| -1% | -$13.9K |
2021 Q2
6 quarters
|
|
|
BLNG
489
DELISTED
Belong Acquisition Corp. Class A Common Stock
BLNG
| $1.43M | 0.03% |
144,185
| – | – |
2021 Q3
5 quarters
|
|
|
DISH
490
PUT
DELISTED
DISH Network Corp.
DISH
| $1.42M | 0.03% |
62,600
| – | – |
2021 Q2
6 quarters
|
|
491
Extra Space Storage
EXR
$29.1B
| $1.41M | 0.03% |
9,581
-62,345
| -87% | -$9.96M |
2021 Q1
7 quarters
|
|
492
Karyopharm Therapeutics
KPTI
$7.96M
| $1.41M | 0.03% |
27,621
+9,540
| +53% | +$661K |
2022 Q1
3 quarters
|
|
493
Agios Pharmaceuticals
AGIO
$1.93B
| $1.4M | 0.03% |
+50,000
| New | +$1.41M |
2022 Q4
0 quarters
|
|
494
DELISTED
89bio
ETNB
| $1.39M | 0.03% |
109,290
+17,256
| +19% | +$155K |
2022 Q3
1 quarter
|
|
495
SunPower Inc
SPWR
$84.1M
| $1.38M | 0.03% |
136,747
| – | – |
2021 Q2
6 quarters
|
|
|
PACX
496
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $1.38M | 0.03% |
135,868
-1,335
| -1% | -$13.4K |
2021 Q1
7 quarters
|
|
497
Tarsus Pharmaceuticals
TARS
$3.32B
| $1.37M | 0.03% |
93,500
+32,500
| +53% | +$538K |
2022 Q3
1 quarter
|
|
498
Autolus Therapeutics
AUTL
$458M
| $1.37M | 0.03% |
720,960
+136,554
| +23% | +$345K |
2022 Q1
3 quarters
|
|
499
DELISTED
Ventyx Biosciences
VTYX
| $1.37M | 0.03% |
41,787
+12,387
| +42% | +$367K |
2022 Q3
1 quarter
|
|
500
Iovance Biotherapeutics
IOVA
$6.67B
| $1.36M | 0.03% |
213,535
+10,663
| +5% | +$83.2K |
2022 Q1
3 quarters
|
|
Similar funds
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.
- UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
- UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
- UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.